Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private

BSE1427.001 (+0.07 %)

PREV CLOSE ( ) 1426.00

OPEN PRICE ( ) 1448.80

BID PRICE (QTY) 1427.00 (12)

OFFER PRICE (QTY) 1429.65 (39)

VOLUME 4490

TODAY'S LOW / HIGH ( )1418.40 1458.80

52 WK LOW / HIGH ( )496.35 1513.75

NSE1428.203.75 (+0.26 %)

PREV CLOSE( ) 1424.45

OPEN PRICE ( ) 1437.00

BID PRICE (QTY) 1428.20 (7)

OFFER PRICE (QTY) 1429.40 (9)

VOLUME 31430

TODAY'S LOW / HIGH( ) 1418.00 1444.80

52 WK LOW / HIGH ( )498.05 1513.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-08 2004

Management Info

Naresh Trehan - Chairman Naresh Trehan - Managing Director

Registered Office

Address Medanta- Mediclinic,E-18, Defence Colony,,
New Delhi,
Delhi-110024

Phone 011-44114411

Email info@medanta.org

Website www.medanta.org

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

27Mar Announcement under Regulation 30 (LOD
Allotment of Equity Shares, pursuant to exercise of ESOPs under GHL - Em..

16Mar Global Health informs about trading wi
Global Health has informed that as per SEBI (Prohibition of Insider Trad..

16Feb Global Health submits analyst meet int
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..

08Feb Statement Of Deviation/Variation In U
Statement of Deviation/variation in utilization of funds raised by IPO ,..

29Nov Global Health informs about resignatio
Global Health has informed that Sanjeev Kumar, Group Chief Financial Off..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	873.45	2632.45
Gross Profit	1208.73	3517.05
Operating Profit	1483.62	4639.55
Net Sales	5616.78	19594.46

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

RainbowChildrenS Med (BSE) 1436.80 (3.65%)	M.Cap ( in Cr)14441.15
Dr Agarwals Eye Hsp (BSE) 3544.00 (1.19%)	M.Cap ( in Cr)1658.87
Apollo Hospital Ent. (BSE) 5996.10 (0.67%)	M.Cap ( in Cr)86214.00
Jupiter Life Line (BSE) 1221.70 (1.29%)	M.Cap ( in Cr)8058.39
Fortis Healthcare (BSE) 450.25 (2.19%)	M.Cap ( in Cr)33991.99

Shareholding Pattern

	NON-INSTITUTION	44.61%
	PROMOTERS	33.04%
	MUTUAL FUNDS/UTI	8.27%
	FI/BANKS/INSURANCE	1.03%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Invesco India Focus...	5.76
Motilal Oswal ELSS ...	5.09
Edelweiss Recently ...	4.86
Motilal Oswal Large...	4.66
HSBC Consumption Fu...	4.33
LIC MF Healthcare F...	3.86
SBI Healthcare Opp ...	3.77

Risk Disclosures on Derivatives

Smart Quotes

GLOBAL HEALTH LTD.